Metformin improves endotoxemia and alters folliculogenesis in women with polycystic ovary syndrome
Authors:
Open Access
- 17 April 2026
- journal article
- Published by Bioscientifica in Endocrine Connections
- Vol. 15 (5)
Abstract
Polycystic ovary syndrome (PCOS) is associated with excessive ovarian androgen production, an increased number of ovarian follicles and a wide range of other endocrine and metabolic derangements, including endotoxemia. Metformin is often used in the treatment of PCOS, especially to improve glucose metabolism. This study evaluated the effects of metformin on endotoxemia, folliculogenesis and endocrine profiles. In a prospective trial, women with PCOS received metformin (500 mg t.i.d.) for three months and underwent baseline and post-treatment evaluations of their endocrine and metabolic profiles as well as detailed ultrasonographic evaluations of ovaries. Metformin treatment was associated with reduced lipopolysaccharides (LPSs) by 19% (P < 0.0001) and LPS-binding protein (LPB) by 26% (P < 0.0001). In parallel, the number of small antral follicles (<6 mm) declined by 8% (P = 0.005), total testosterone decreased by 13% (P = 0.0003), ovarian testosterone production in response to hCG declined by 73% (P = 0.03), and fasting insulin decreased by 19% (P = 0.02). The reduction in testosterone following treatment with metformin may be due to a combination of multiple effects of metformin, including improvement in endotoxemia, reduction in folliculogenesis and decreased insulin. Clinical trial registration number: NCT03489668Keywords
This publication has 39 references indexed in Scilit:
- Metformin has direct effects on human ovarian steroidogenesisFertility and Sterility, 2003
- Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndromeFertility and Sterility, 2000
- A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic ProfileThe Journal of Clinical Endocrinology & Metabolism, 1999
- Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.Diabetes Care, 1999
- Insulin Stimulates Testosterone Biosynthesis by Human Thecal Cells from Women with Polycystic Ovary Syndrome by Activating Its Own Receptor and Using Inositolglycan Mediators as the Signal Transduction System1The Journal of Clinical Endocrinology & Metabolism, 1998
- Insulin and insulin-like growth factor I stimulate the proliferation of human ovarian theca-interstitial cellsFertility and Sterility, 1998
- Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands.The Journal of Clinical Endocrinology & Metabolism, 1996
- Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancyMetabolism, 1994
- Insulin infusion acutely augments ovarian androgen production in normal womenFertility and Sterility, 1990
- Androgen Production by Theca and Granulosa Isolated from Proestrous Rat Follicles1Endocrinology, 1977